Grove AI Inc., a provider of an AI-powered advanced clinical research platform raised $4.9 million in Seed funding.
The round was led by A*, with participation from Afore Capital, LifeX Ventures, Pear VC, Upfront Ventures, and angels including Ajit Baid, Chloe Yoo, Phuc Truong, Till Pieper.
San Francisco-based company Grove AI said that it plans to use the funds to continue scaling its team and product to redefine clinical trials from siloed operations into participant-centered ecosystems driven by real-time data.
Grove AI offers a software platform called Grace that automates and enhances your clinical trial operations at scale using Institutional review boards (IRBs)-approved scripts and processes. Its platform streamlines end-to-end participant engagement, recruitment, and follow-up, eliminating bottlenecks and ensuring scalability for clinical trial and research teams.